• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan.

作者信息

Narimatsu Hiroto, Hori Akiko, Matsumura Tomoko, Kodama Yuko, Takita Morihito, Kishi Yukiko, Hamaki Tamae, Yuji Koichiro, Tanaka Yuji, Komatsu Tsunehiko, Kami Masahiro

出版信息

J Clin Oncol. 2008 Dec 10;26(35):5820-3. doi: 10.1200/JCO.2008.20.3307. Epub 2008 Nov 10.

DOI:10.1200/JCO.2008.20.3307
PMID:19001340
Abstract
摘要

相似文献

1
Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan.制药公司、学术界和媒体之间的合作关系解释了日本硼替佐米治疗后肺部并发症发生率急剧下降的原因。
J Clin Oncol. 2008 Dec 10;26(35):5820-3. doi: 10.1200/JCO.2008.20.3307. Epub 2008 Nov 10.
2
[Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical Hematology].[日本复发/难治性多发性骨髓瘤中硼替佐米治疗相关的肺损伤：日本血液学会和日本临床血液学会“硼替佐米所致肺损伤”联合委员会基于问卷调查的报告]
Rinsho Ketsueki. 2006 Dec;47(12):1521-7.
3
Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?硼替佐米治疗多发性骨髓瘤后发生的严重肺部并发症：一种未被认识的肺血管炎？
Leuk Res. 2007 Jul;31(7):1027-8. doi: 10.1016/j.leukres.2006.09.015. Epub 2006 Nov 28.
4
Severe pulmonary complications after bortezomib treatment in multiple myeloma.硼替佐米治疗多发性骨髓瘤后的严重肺部并发症
Hematol Oncol. 2010 Mar;28(1):49-52. doi: 10.1002/hon.924.
5
Bortezomib-related diffuse alveolar hemorrhage.
J Clin Oncol. 2012 Dec 20;30(36):e379-81. doi: 10.1200/JCO.2012.43.6519. Epub 2012 Nov 13.
6
[Clinical development of a proteasome inhibitor, bortezomib, for the treatment of myeloma and lymphoma].蛋白酶体抑制剂硼替佐米用于治疗骨髓瘤和淋巴瘤的临床开发
Rinsho Ketsueki. 2007 Jun;48(6):451-7.
7
Deafness associated with the use of Bortezomib in multiple myeloma.与硼替佐米用于多发性骨髓瘤相关的耳聋。
Acta Oncol. 2008;47(2):323-4. doi: 10.1080/02841860701558823.
8
Bortezomib-induced skin eruption.硼替佐米引起的皮肤疹。
Dermatology. 2008;216(2):156-8. doi: 10.1159/000111513. Epub 2008 Jan 23.
9
Pulmonary fibrosis in a myeloma patient on bortezomib treatment. A new severe adverse effect of a new drug.硼替佐米治疗的骨髓瘤患者出现肺纤维化。一种新药的新型严重不良反应。
Am J Hematol. 2007 Jun;82(6):502-3. doi: 10.1002/ajh.20891.
10
The impact of bortezomib on the risk of thrombosis in multiple myeloma.
Leuk Res. 2011 Feb;35(2):145-6. doi: 10.1016/j.leukres.2010.09.017. Epub 2010 Oct 16.

引用本文的文献

1
Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD).当前和新兴的结缔组织病-间质性肺病（CTD-ILD）药物治疗。
Drugs. 2019 Sep;79(14):1511-1528. doi: 10.1007/s40265-019-01178-x.
2
Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature.硼替佐米诱导的肺毒性：一例病例报告及文献综述
Case Rep Med. 2018 Nov 25;2018:2913124. doi: 10.1155/2018/2913124. eCollection 2018.
3
Approving molecularly targeted drugs: different approval processes for cytotoxic agents.批准分子靶向药物：细胞毒性药物的不同批准程序。
Int J Clin Oncol. 2016 Oct;21(5):1004-1013. doi: 10.1007/s10147-016-0980-2. Epub 2016 Apr 22.
4
How do medical journalists treat cancer-related issues?医学记者如何处理与癌症相关的问题？
Ecancermedicalscience. 2015 Jan 26;9:502. doi: 10.3332/ecancer.2015.502. eCollection 2015.
5
A quantitative analysis of the mass media coverage of genomics medicine in China: a call for science journalism in the developing world.中国大众媒体对基因组医学报道的定量分析：呼吁发展中国家开展科学新闻报道
OMICS. 2014 Apr;18(4):222-30. doi: 10.1089/omi.2013.0108. Epub 2014 Feb 10.
6
Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: incidence, mortality and clinical characterization.硼替佐米治疗相关肺部疾病在日本多发性骨髓瘤患者中的发病情况、死亡率和临床特征。
Cancer Sci. 2014 Feb;105(2):195-201. doi: 10.1111/cas.12335. Epub 2014 Jan 21.
7
Bortezomib-induced bronchiolitis obliterans organizing pneumonia.硼替佐米诱导的闭塞性细支气管炎并机化性肺炎。
Case Rep Pulmonol. 2012;2012:430141. doi: 10.1155/2012/430141. Epub 2012 Oct 21.
8
Coverage of genomic medicine: information gap between lay public and scientists.基因组医学的覆盖范围：公众与科学家之间的信息差距。
Risk Manag Healthc Policy. 2012;5:83-90. doi: 10.2147/RMHP.S33661. Epub 2012 Aug 2.
9
Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β(1) signalling.损伤后蛋白酶体抑制通过调节 TGF-β(1)信号转导防止纤维化。
Thorax. 2012 Feb;67(2):139-46. doi: 10.1136/thoraxjnl-2011-200717. Epub 2011 Sep 15.
10
Proteasomal regulation of pulmonary fibrosis.蛋白酶体对肺纤维化的调节。
Proc Am Thorac Soc. 2010 Feb;7(1):77-83. doi: 10.1513/pats.200906-055JS.